retatrutide trial news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Delivers A1C Reduction, Weight

GHK-Cu is endogenous your body naturally produces it

Prospective identification of tumorigenic breast cancer cells

Medical Oversight How Each Program Monitors Your Progress Amazon One Medical: GLP-1 management integrated into ongoing primary care relationship Regular follow-up appointments with the same provider over time Integrated lab work and cardiovascular monitoring Clinician visibility into full health picture not just weight loss metrics Dose adjustments handled through scheduled consultations with continuity provider Strongest medical oversight model currently available in the GLP-1 telehealth market Direct Meds: Licensed provider review at intake and prescription issuance Nurse support included throughout treatment period Telehealth-based ongoing access for clinical questions Less integrated with broader primary care than Amazon's model Appropriate for patients whose primary care relationship exists separately The bottom line on oversight: Amazon One Medical offers a meaningfully more integrated and clinically comprehensive oversight model

A minor modification was made in position 34 to ensure the attachment of only one fatty di-acid

In clinical trials of Wegovy, alopecia was reported in about 3% of adult patients on the medication versus 1% on placebo

After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead